Structure Therapeutics Inc. - 8-K Filing
Structure Therapeutics Inc. amended its Sales Agreement with Leerink Partners LLC and Cantor Fitzgerald & Co., removing limits on the aggregate offering amount for American Depositary Shares (ADSs). The company also filed a prospectus supplement to increase available shares under an at-the-market program by $150 million, raising the total potential offering price of ADSs up to $400 million. Previously, it had sold 3,040,000 ADSs for gross proceeds of approximately $58.52 million. (Items: 1.01 Entry into a Material Definitive Agreement, 2.02 Results of Operations and Financial Condition, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $GPCR